RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Pretax margin (%)

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 202433.7+5.13%
Dec 31, 202332-19.80%
Dec 31, 202239.9-31.21%
Dec 31, 202158+29.40%
Dec 31, 202044.8+45.17%
Dec 31, 201930.9-18.82%
Dec 31, 201838.1+7.50%
Dec 31, 201735.4+29.37%
Dec 31, 201627.4-8.35%
Dec 31, 201529.9+8.51%
Dec 31, 201427.5-18.82%
Dec 31, 201333.9+12.74%
Dec 31, 201230.1-160.13%
Dec 31, 2011-50+119.70%
Dec 31, 2010-22.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)